Ciprofloxacin

Product NDC: 60760-690
11-digit product format: 607600690
Labeler code: 60760
Product ID: 60760-690_348e9276-54df-fa85-e063-6394a90a5d26
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: Ciprofolxacin
Dosage form: TABLET
Route: ORAL
Labeler: ST. MARY'S MEDICAL PARK PHARMACY
Application: ANDA208921
Marketing category: ANDA
Marketing start: 2023-10-01
Substance: CIPROFLOXACIN HYDROCHLORIDE
Active strength: 250 mg/1
Pharmacologic classes: Cytochrome P450 1A2 Inhibitors [MoA], Fluoroquinolone Antibacterial [EPC], Fluoroquinolones [CS]
NDC exclude flag: No
Listing certified through: 2026-12-31
Current FDA listing: Yes

openFDA Listing Details

Product ID: 60760-690_348e9276-54df-fa85-e063-6394a90a5d26
SPL ID: 348e9276-54df-fa85-e063-6394a90a5d26
Product type: HUMAN PRESCRIPTION DRUG
Finished product: Yes
Brand name base: Ciprofloxacin
Generic name: Ciprofolxacin
Dosage form: TABLET
Route: ORAL
Marketing start: 2023-10-01
Marketing category: ANDA
Application number: ANDA208921
Pharmacologic classes: Cytochrome P450 1A2 Inhibitors [MoA]; Fluoroquinolone Antibacterial [EPC]; Fluoroquinolones [CS]
Listing expiration: 2026-12-31

Ingredient	Strength
CIPROFLOXACIN HYDROCHLORIDE	250 mg/1

Field	Values
Unii	4BA73M5E37
Rxcui	197511
Spl Set Id	348e810c-e572-f3d2-e063-6394a90a0855
Manufacturer Name	ST. MARY'S MEDICAL PARK PHARMACY

Package NDC	Description	Marketing start	Sample
60760-690-10	10 TABLET in 1 BOTTLE, PLASTIC (60760-690-10)	2025-05-07	No

UNII	Preferred term	Registry number	Matched term
4BA73M5E37	CIPROFLOXACIN HYDROCHLORIDE	86393-32-0	CIPROFLOXACIN HYDROCHLORIDE

Package NDC	11-digit format	Description	Units	Marketing start	Sample	Exclude flag	Status
60760-690-10	60760069010	10 TABLET in 1 BOTTLE, PLASTIC (60760-690-10)	10 tablet	2025-05-07	No	No	Historical

Title	Manufacturer	Effective date	Type	Version
Ciprofloxacin	ST. MARY'S MEDICAL PARK PHARMACY	2025-05-07	HUMAN PRESCRIPTION DRUG LABEL	1